ObjectiveTo characterise the relaxation induced by the soluble guanylate cyclase (sGC) activator, BAY 60-2770 (4-({(4-carboxybutyl) [2-(5-fluoro-2-{[4 0 -(trifluoromethyl) biphenyl-4-yl]methoxy}phenyl)ethyl] amino}methyl)benzoic acid) in rabbit corpus cavernosum (CC).
Material and MethodsThe penis from male New Zealand rabbits was removed and fours strips of CC were obtained. Concentration-response curves to BAY 60-2770 were constructed in the absence and presence of inhibitors of nitric oxide synthase, N (G)-nitro-Larginine methyl ester (L-NAME, 100 lM), sGC, 1H-[1,2,4] oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 lM) and phosphodiesterase type 5 (PDE-5), tadalafil (0.1 lM). The potency (pEC 50 ) and maximal response (E max ) values were determined. Then, electrical-field stimulation (EFS)-induced contraction or relaxation was tested in the absence and presence of BAY 60-2770 (0.1 or 1 lM) alone or combined with ODQ (10 lM). For EFS-induced relaxation two protocols were used: (i) ODQ (10 lM) was first incubated for 20 min and then BAY 60-2770 (1 lM) was added for another 20 min (ODQ + BAY 60-2770); (ii) in different CC strips, BAY 60-2770 was incubated for 20 min followed by another 20 min with ODQ (BAY 60-2770 + ODQ). The intracellular levels of cyclic guanosine monophosphate (cGMP) were also determined.
ResultsBAY 60-2770 potently relaxed rabbit CC with mean (SEM) pEC 50 and E max values of 7.58 (0.19) and 81 (4)%, respectively. The inhibitors ODQ (n = 7) or tadalafil (n = 7) produced 4.2-and 6.3-leftward shifts, respectively in BAY 60-2770-induced relaxation without interfering with the E max values. The intracellular levels of cGMP were augmented after stimulation with BAY 60-2770 (1 lM) alone, whereas its coincubation with ODQ produced even higher levels of cGMP. The EFS-induced contraction was reduced in the presence of BAY 60-2770 (1 lM) and this inhibition was even greater when BAY 60-2770 was co-incubated with ODQ. The nitrergic stimulation induced CC relaxation, which was abolished in the presence of ODQ. BAY 60-2770 alone increased the amplitude of relaxation. Co-incubation of ODQ and BAY 60-2770 did not alter the relaxation in comparison with ODQ alone. Interestingly, when BAY 60-2770 was incubated before ODQ, EFS-induced relaxation was partly restored in comparison with ODQ alone or ODQ + BAY 60-2770.
ConclusionsThe relaxation induced by the sGC activator, BAY 60-2770 was increased after sGC oxidation and unaltered in the absence of nitric oxide. Thus, this class of substances may have advantages over sGC stimulators or PDE-5 inhibitors for treating patients with erectile dysfunction and extensive endothelial damage.